Skip to Main Content

Author Details

Vicky S Sabine
University of Guelph
2004
20
15
PMIDPaper TitleJournal TitlePublished Year
31013327Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.PLoS One2019
31282052Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs.Cytometry A2019
29470143Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.J Clin Oncol2018
30420699Pathway-based subnetworks enable cross-disease biomarker discovery.Nat Commun2018
27290644KRAS Mutations in Canine and Feline Pancreatic Acinar Cell Carcinoma.J Comp Pathol2016
27384960Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.Sci Rep2016
25071141Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study.J Clin Oncol2014
23301057PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer.PLoS One2013
22168172Validation of activated caspase-3 antibody staining as a marker of apoptosis in breast cancer.Histopathology2012
20941539The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study.Breast Cancer Res Treat2011
22133085Relative impact of key sources of systematic noise in Affymetrix and Illumina gene-expression microarray experiments.BMC Genomics2011
21320304Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer.Mol Cancer2011
20181233Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles.BMC Genomics2010
20480226Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer.Breast Cancer Res Treat2010
18426733Expression of tumor necrosis factor alpha converting enzyme in endocrine cancers.Am J Clin Pathol2008
18823667Hepatic transcriptomic profiles of European flounder (Platichthys flesus) from field sites and computational approaches to predict site from stress gene responses following exposure to model toxicants.Aquat Toxicol2008
18804290Transcriptomic responses of European flounder (Platichthys flesus) to model toxicants.Aquat Toxicol2008
17156945Gene expression responses of European flounder (Platichthys flesus) to 17-beta estradiol.Toxicol Lett2007
17120584Development of the GENIPOL European flounder (Platichthys flesus) microarray and determination of temporal transcriptional responses to cadmium at low dose.Environ Sci Technol2006
15178084A comparison of pollutant biomarker responses with transcriptional responses in European flounders (Platicthys flesus) subjected to estuarine pollution.Mar Environ Res2004
  • 1 - 20 of 20

Recommended Authors

University of Toronto
Career Start Year 2011
Number of shared co-authors 1
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 1
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
University of British Columbia
Career Start Year 2007
Number of shared co-authors 2
UCD Conway Institute, University College Dublin
Career Start Year 2006
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 1
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 1
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 2004
Number of shared co-authors 0
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 4
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 1
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 1
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 2
University of Oslo
Career Start Year 1997
Number of shared co-authors 1
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 3
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 2
University Health Network
Career Start Year 1994
Number of shared co-authors 3
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 1
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 7
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 1
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 7
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 4
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 2
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 9
University of Toronto
Career Start Year 1977
Number of shared co-authors 4
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 0

Collaborators

University of Edinburgh
Co-authored papers 14
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 3
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 3
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Leicester Clinical Trials Unit, University of Leicester
Co-authored papers 2
MRC Institute of Genetics and Molecular Medicine, University of Edinburgh
Co-authored papers 2
Erasmus Medical Center
Co-authored papers 2
University Medical Center, Johannes Gutenberg University Mainz
Co-authored papers 2
Helios Medical Centre
Co-authored papers 2
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 2
National and Kapodistrian University of Athens
Co-authored papers 2
University of Edinburgh
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
University of Cambridge
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Institute for Integrative Systems Biology, Spanish National Research Council (CSIC)
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Institute of Cancer Research
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Maastricht University
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Co-authored papers 1
Kresge Eye Institute/Wayne State University Department of Ophthalmology
Co-authored papers 1